Characterization and Transmission Dynamics of Carbapenemase-Encoding Genes in Carbapenem-Resistant Enterobacter cloacae (CREC)

Study Background and Research Question

Carbapenem-resistant Enterobacteriaceae (CRE) have become a major public health concern, with Enterobacter cloacae (CREC) representing a significant and increasing component of this threat, especially in Chinese hospitals. The COVID-19 pandemic has further complicated antimicrobial stewardship by driving up empirical antibiotic use, interrupting healthcare processes, and facilitating the spread of multidrug-resistant organisms. While the role of carbapenemase-encoding genes (CEGs) such as blaNDM-1, blaIMP, and blaKPC-2 in mediating resistance is established, detailed regional data on their prevalence, genetic context, and ability to transmit horizontally and vertically during the pandemic period remain scarce. The central research question addressed by Chen et al. (2025) is: What are the molecular characteristics and transmission dynamics of CEGs in CREC isolates from multiple hospitals in Guangdong province during and after the COVID-19 pandemic?
(source: paper)

Key Innovation from the Reference Study

This study’s primary innovation lies in its comprehensive, multi-institutional analysis of 54 CREC isolates collected between December 2022 and June 2024. By combining variable temperature SDS plasmid elimination, PCR, plasmid conjugation assays, and genotyping, the authors delineate both the genetic localization of carbapenemase genes (chromosomal vs. plasmid) and their transferability within clinical environments. Unlike prior reports that focused on single-hospital populations or lacked direct transmission assessments, this work quantifies both the prevalence and mobility of CEGs, especially plasmid-borne blaNDM-1, providing actionable insights into the mechanisms fueling CREC dissemination.
(source: paper)

Methods and Experimental Design Insights

The investigators collected non-redundant CREC isolates from eight teaching hospitals, ensuring representation across clinical departments and patient demographics. CEGs were detected using targeted PCR for blaNDM-1, blaIMP, and blaKPC-2, with their localization (plasmid or chromosomal) determined via variable temperature SDS plasmid elimination. Broth microdilution established antimicrobial susceptibility profiles. Conjugation assays were performed to assess horizontal gene transfer efficiency. Genotyping (ERIC-PCR) and NTSYS analysis enabled high-resolution clustering of isolates by genetic type. Mobile genetic elements associated with CEGs were identified, with a particular focus on ISEcp1 and its role in gene mobilization.
(source: paper)

Protocol Parameters

• assay | variable temperature SDS plasmid elimination | 54 isolates | Used to distinguish plasmid vs. chromosomal localization of resistance genes | paper
• assay | PCR for blaNDM-1, blaIMP, blaKPC-2 | 54 isolates | Sensitive detection and differentiation of key carbapenemase gene subtypes | paper
• assay | Broth microdilution | MIC determination (μg/mL) | Quantitative assessment of multidrug resistance patterns | paper
• assay | Plasmid conjugation transfer | 46 CEG-positive isolates | Direct measurement of horizontal gene transfer capacity | paper
• genotyping | ERIC-PCR + NTSYS clustering | 54 isolates | High-resolution differentiation of genotypes and epidemiological tracing | paper

Core Findings and Why They Matter

The study yielded several critical findings:

• High Prevalence of CEGs: 85.19% of CREC isolates carried carbapenemase-encoding genes, with blaNDM-1 being the most frequent (found on both plasmids and chromosomes in 33.33% of isolates, and exclusively on plasmids in 46.30%). A minority harbored blaIMP or both blaNDM-1 and blaKPC-2 (source: paper).
• Plasmid Localization and Transferability: Plasmid-borne CEGs are highly transmissible: 95.65% of CEG-positive isolates successfully transferred resistance genes in conjugation experiments. The blaNDM-1 gene was particularly mobile (95.45% transfer success), while blaIMP was transferred in 100% of tested cases (source: paper).
• Multidrug Resistance: CEG-positive isolates exhibited significantly higher resistance rates to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin compared to CEG-negative strains (P<0.05), confirming the clinical challenge posed by these genotypes (source: paper).
• Molecular Epidemiology: Six types of mobile genetic elements were identified, with ISEcp1 present in 87.04% of isolates. The most common scenario was CREC harboring four types of MGEs simultaneously, indicating a high potential for gene shuffling and resistance evolution (source: paper).
• Genotypic Diversity and Epidemiological Trends: ERIC-PCR typing revealed 17 genotypes, with type E and type G each comprising over 20% of isolates and distributed across multiple hospitals and departments. Higher detection rates were seen in men, elderly patients, respiratory medicine wards, and sputum samples, pointing toward vulnerable populations and transmission hotspots (source: paper).

These findings collectively demonstrate that the predominance of plasmid-localized blaNDM-1 and associated mobile genetic elements underpin the rapid horizontal spread of multidrug resistance among CREC in diverse clinical settings.

Comparison with Existing Internal Articles

The results of this study provide a crucial molecular foundation that complements and expands on several internal resources. For example, "Tigecycline: Glycylcycline Antibiotic for Multidrug-Resistant Bacteria" (compound-56.com) discusses the efficacy of tigecycline against multidrug-resistant Enterobacteriaceae, including mechanisms relevant to protein synthesis inhibition. However, the present paper’s focus on the genotypic drivers of carbapenem resistance, especially the epidemiology of CEGs, adds granularity to existing pharmacological discussions. Additionally, the internal article "Transmission Dynamics of Carbapenemase Genes in CREC, 2022–2024" (gdc-0879.com) provides an overview that is directly based on this reference study, offering a broader antimicrobial strategy context. Finally, "Tigecycline Workflows: Advanced Applications in MDR Bacteria Research" (hmn-214.com) translates molecular insights like those from Chen et al. into practical bench protocols, highlighting the bridge from genotype surveillance to antimicrobial testing workflows.

Limitations and Transferability

While the study is notable for its breadth and depth, it is constrained by its regional focus (Guangdong, China) and the relatively short sampling period (2022–2024). The 54-isolate sample, while diverse, may not capture the full heterogeneity of CREC genotypes across China or globally. Additionally, while the study confirms high transferability of certain CEGs in vitro, the in vivo clinical transfer dynamics, potential environmental reservoirs, and the impact of infection control interventions were not assessed. Nevertheless, the robust methodology and high-resolution molecular data provide a valuable template for surveillance in other regions, especially where multidrug-resistant Enterobacteriaceae are rising threats.

Research Support Resources

To advance laboratory research on multidrug-resistant Enterobacteriaceae, validated reagents and standards are essential for reproducibility. Researchers investigating antimicrobial agents for multidrug-resistant bacteria—such as those seeking to evaluate novel therapeutics or assess gene-drug interactions—can utilize Tigecycline (SKU A5226), a first-in-class glycylcycline antibiotic with potent activity against both carbapenemase-producing and non-carbapenemase-producing strains. APExBIO provides this compound with detailed specifications to support studies ranging from MIC determination to experimental infection models, enabling rigorous benchmarking and translational research.
(source: workflow_recommendation)